Matvey Lukashev
AeroLeads people directory · profile

Matvey Lukashev Email & Phone Number

Drug development consultant (pro bono) at ALS Therapy Development Institute
Location: Cambridge, Massachusetts, United States 12 work roles 2 schools
1 work email found @als.net 3 phones found area 617 and 781 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email m****@als.net
Direct phone (617) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
ALS Therapy Development Institute
Role
Drug development consultant (pro bono)
Location
Cambridge, Massachusetts, United States
Company size
61 employees

Who is Matvey Lukashev? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Matvey Lukashev is listed as Drug development consultant (pro bono) at ALS Therapy Development Institute, a with 61 employees, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at als.net, phone signal with area code 617, 781, and a matched LinkedIn profile for Matvey Lukashev.

Matvey Lukashev previously worked as Vice President, Research and Preclinical Development at Nervgen Pharma Corp. and Vice President, Translational Sciences at Als Therapy Development Institute. Matvey Lukashev holds Ms, Biochemistry. Bioorganic Chemistry from Lomonosov Moscow State University (Msu).

Company email context

Email format at ALS Therapy Development Institute

This section adds company-level context without repeating Matvey Lukashev's masked contact details.

{first_initial}{last}@als.net
89% confidence

AeroLeads found 1 current-domain work email signal for Matvey Lukashev. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Matvey Lukashev

• 25 years of industry experience across all stages of drug development in oncology, immunology/fibrosis, and neurology • Broad therapeutic indication and target class experience in translational research, clinical dvelopment, and discovery settings• Record of successful project initiation and cross-functional project team leadership in translational and discovery research• Familiarity with clinical development, clinical trial operations and logistics for biomarker studies

Listed skills include Biomarkers, Immunology, Drug Discovery, Biotechnology, and 43 others.

Current workplace

Matvey Lukashev's current company

Company context helps verify the profile and gives searchers a useful next step.

ALS Therapy Development Institute
Als Therapy Development Institute
Drug development consultant (pro bono)
Boston, MA, US
Website
als.net
Employees
61
AeroLeads page
Company profile
View company profile Email format
12 roles · 36 years

Matvey Lukashev work experience

A career timeline built from the work history available for this profile.

Vice President, Research And Preclinical Development

Current
Nervgen Pharma Corp.

Vancouver, British Columbia, Ca

Discovery and preclinical development of therapeutics targeting CNS repair

Sep 2022 - Present

Senior Director, Cell Biology And Translational Research

Als Therapy Development Institute

Watertown, Massachusetts, Us

Built and led a new translational research function encompassing patient genomics and phenomics, stem cell biology (iPSC and their derivatives) and genome editing for biomarker, target and drug discovery in amyotrophic lateral sclerosis.

Jan 2018 - Jan 2021

Sab Member

Current
Cellibrium Biosciences
Sep 2021 - Present

Principal Scientist

Biogen Idec

Cambridge, Ma, Us

• Tecfidera® Research Lead (through 2010), Program Team member. Characterized the molecular and cellular mechanisms of action, led biomarker discovery supporting clinical development of Tecfidera®. Provided and led research support for multiple aspects of the clinical development program, including the publication regulatory, legal, and risk mitigation strategies. Participated in foreign regulatory agency discussions and meetings. Designed biomarker strategies for Phase 2 and 3 clinical studies. • Project leader for an exploratory monoclonal antibody target validation program in immunology. Identified the target through analysis of clinical genomic data. Developed the project, led cross-functional project team.• Project leader for small molecule discovery projects targeting metabolic stress response. Identified the target pathway and molecular intervention points, developed and led the discovery projects focusing on structure-based drug design, biochemical screening, and phenotypic screening approaches.• Recipient of Biogen Idec Outstanding Achievement Award (2012)

Jan 2007 - Aug 2012

Senior Scientist

Biogen Idec

Cambridge, Ma, Us

• BG12 (Tecfidera®) Research Lead (since 2005). Led BG12 mechanism of action analysis and biomarker discovery. Developed MOA-based rationale for potential new indications, combination therapy uses, and follow-on compound identification. Supported program-related external opportunity evaluation and due diligence efforts, co-managed external collaborator network.• Using gene expression analysis methods, characterized mechanism of in vivo action, identified candidate biomarkers of drug response and efficacy, and provided data informing therapeutic candidate selection for a pre-IND program developing a monoclonal antibody for treatment of fibrotic disease. Generated data provided a strategic basis for subsequent clinical development of the therapy.

2003 - 2006 ~3 yrs

Scientist Ii

Biogen,

• Co-leader of the Angiogenesis program. Responsible for selection and validation of targets and candidate therapeutic agents for modulation of angiogenesis. • Led mechanism of action studies and identification of clinically relevant pharmacodynamic biomarkers to inform preclinical and clinical development of a monoclonal antibody for treatment of solid tumors. Established a predictive in vitro cell-based platform for preclinical prediction of tumor response and biomarker discovery. • Co-developed a new approach to the mining of transcript profiling data.• Member, Joint Research Management Committee and Head, genomics data mining team for a tumor antigen discovery program (Biogen-EOS Biotechnology collaboration).

Oct 1998 - Dec 2002

Postgraduate Researcher

Ucsf

San Francisco, California, Us

1994 - 1998 ~4 yrs
Team & coworkers

Colleagues at ALS Therapy Development Institute

Other employees you can reach at als.net. View company contacts for 61 employees →

QP Qinggong Ping Qinggong Ping Colleague at Als Therapy Development InstituteCambridge, Massachusetts, United States View → ED Eva Durich Eva Durich Colleague at Als Therapy Development InstituteArgentina View → SR Sara R Sara R Colleague at Als Therapy Development InstituteBritish Columbia, Canada View → EH Eric Hebert Eric Hebert Colleague at Als Therapy Development InstituteBoston, Massachusetts, United States View → MD Michele Dupree Michele Dupree Colleague at Als Therapy Development InstituteHighlands, New Jersey, United States View → AG Anna Gill Anna Gill Colleague at Als Therapy Development InstituteBoston, Massachusetts, United States View → GM Glynis Murray Glynis Murray Colleague at Als Therapy Development InstitutePacifica, California, United States View → AC Alessandro Calo Alessandro Calo Colleague at Als Therapy Development InstituteSanta Monica, California, United States View → MF Matt Ferola Matt Ferola Colleague at Als Therapy Development InstituteArlington, Massachusetts, United States View → AM Amit Mishra Amit Mishra Colleague at Als Therapy Development InstituteCambridge, Massachusetts, United States View →
2 education records

Matvey Lukashev education

Ms, Biochemistry. Bioorganic Chemistry

Lomonosov Moscow State University (Msu)

Ph.D., Cell Biology

Russian Academy Of Medical Sciences
FAQ

Frequently asked questions about Matvey Lukashev

Quick answers generated from the profile data available on this page.

What company does Matvey Lukashev work for?

Matvey Lukashev works for ALS Therapy Development Institute.

What is Matvey Lukashev's role at ALS Therapy Development Institute?

Matvey Lukashev is listed as Drug development consultant (pro bono) at ALS Therapy Development Institute.

What is Matvey Lukashev's email address?

AeroLeads has found 1 work email signal at @als.net for Matvey Lukashev at ALS Therapy Development Institute.

What is Matvey Lukashev's phone number?

AeroLeads has found 3 phone signal(s) with area code 617, 781 for Matvey Lukashev at ALS Therapy Development Institute.

Where is Matvey Lukashev based?

Matvey Lukashev is based in Cambridge, Massachusetts, United States while working with ALS Therapy Development Institute.

What companies has Matvey Lukashev worked for?

Matvey Lukashev has worked for Als Therapy Development Institute, Nervgen Pharma Corp., Cellibrium Biosciences, Biogen Idec, and Biogen,.

Who are Matvey Lukashev's colleagues at ALS Therapy Development Institute?

Matvey Lukashev's colleagues at ALS Therapy Development Institute include Qinggong Ping, Eva Durich, Sara R, Eric Hebert, and Michele Dupree.

How can I contact Matvey Lukashev?

You can use AeroLeads to view verified contact signals for Matvey Lukashev at ALS Therapy Development Institute, including work email, phone, and LinkedIn data when available.

What schools did Matvey Lukashev attend?

Matvey Lukashev holds Ms, Biochemistry. Bioorganic Chemistry from Lomonosov Moscow State University (Msu).

What skills is Matvey Lukashev known for?

Matvey Lukashev is listed with skills including Biomarkers, Immunology, Drug Discovery, Biotechnology, Genomics, Drug Development, Assay Development, and In Vitro.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.